Andrew Hore – Quoted Micro 8 February 2021

AQUIS STOCK EXCHANGE Clinical IT developer DXS International (DXSP) is encouraged by the initial results from pilots of the ExpertCare system designed to analyse the electronic records of people with hypertension. DXS is awaiting NHS accreditation. World High Life (LIFE) has appointed Tony Calamita as chief executive. He is a founder of Love Hemp, whose […]

Andrew Hore – Quoted Micro 1 February 2021

AQUIS STOCK EXCHANGE Property investment company Ace Liberty and Stone (ALSP) more than doubled its interim profit. In the six months to October 2020, rental income was 7% lower at £3.22m, while pre-tax profit was 121% higher at £674,000. The profit improvement was due to lower interest charges, offset by a £200,000 write down on […]

Andrew Hore – Quoted Micro 25 January 2021

AQUIS STOCK EXCHANGE Rutherford Health (RUTH) has signed contracts with the NHS that underpin a significant proportion of its fixed costs. More cash will be required in order to take advantage of the potential for the cancer care clinics. The cash will be needed in the next few months and could be raised at the […]

Andrew Hore – Quoted Micro 11 January 2021

AQUIS STOCK EXCHANGE Standard list shell Baskerville Capital (BASK) plans to switch its quotation to the Access segment of the Aquis Stock Exchange. This move will happen at the time of the reverse takeover of Oberon Investments, the owner of fund manager MD Barnard. The transfer to the Access segment is expected to happen on […]

Andrew Hore – Quoted Micro 4 January 2021

AQUIS STOCK EXCHANGE BWA (BWAP) has been unable to sell Kings of The North Corp (KOTN) back to St Georges Eco-Mining and there are problems with the title to claims held by KOTN. It appears that two licences had not been renewed by St Georges. Three more licence areas are being reviewed. St Georges has […]

Andrew Hore – Quoted Micro 14 December 2020

AQUIS STOCK EXCHANGE Incanthera (INC) says that study results for Sol, a sun cream that prevents skin cancer, have been better than expected. There is significantly greater dermal delivery by Sol compared with four rival products and it was found to be a non-irritant. The cream exceeds bioequivalence compared with oral treatments. A new patent […]

Andrew Hore – Quoted Micro 30 November 2020

AQUIS STOCK EXCHANGE Healthcare IT supplier DXS International (DXSP) had £1.2m in cash at the end of October 2020. Net cash was £584,000, following the capitalisation of £568,000 of development spending. Interim revenues improved by 3% to £1.72m but progress was held back by Covid-19. Pre-tax profit jumped from £90,000 to £151,000 due to lower […]